Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1169
  • Home
  • Print this page
  • Email this page

   Table of Contents      
ORIGINAL ARTICLE
Year : 1982  |  Volume : 30  |  Issue : 3  |  Page : 139-141

Tear lysozyme level in patients with trachoma


Department of Ophthalmology, Maulana Azad Medical College, and Guru Nanak Eye Centre, New Delhi, India

Correspondence Address:
D K Sen
Guru Nnak eye centre, New Delhi-110 002
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 7174057

Rights and PermissionsRights and Permissions

How to cite this article:
Sen D K, Sarin G S. Tear lysozyme level in patients with trachoma. Indian J Ophthalmol 1982;30:139-41

How to cite this URL:
Sen D K, Sarin G S. Tear lysozyme level in patients with trachoma. Indian J Ophthalmol [serial online] 1982 [cited 2020 Feb 27];30:139-41. Available from: http://www.ijo.in/text.asp?1982/30/3/139/28193

Table 2

Click here to view
Table 2

Click here to view
Table 1

Click here to view
Table 1

Click here to view
Our preliminary observation showed lyso­zyme level in tears in persons with active trac­homa to be lower as compared to normal per­sons[1]. It has been observed that the level of lysozyme in tears in keratoconjunctivitis sicca tended to decrease with the severity of disease[2]. Minton observed some patients with healed trachoma showing absolutely no tear lyso­zyme[3] However, there is no comprehensive study on the subject available in the literature The purpose of this study was to find out the tear lysozyme level in different stages of trac­homa including healed trachoma and evaluate the results statistically.


  Materials and methods Top


Seventy three patients with trachoma with their age ranging between 16 and 45 years were consecutively chosen from the Outpatient De­partment of Guru Nanak Eye Centre, New Delhi. Seventy five healthy persons with similar age and sex distribution were also cho­sen to serve as control. The diagnosis of trac­homa was made by clinical examination includ­ing slit-lamp biomicroscopy and the stages were determined in accordance with MacCal­lan's classification as modified by W.H.O.[4],[5]

Tear Samples were collected as described previously and stored at-20° until assayed.[6] Tear lysozyme was quantified by employing a single radial immunodiffusion technique. Monospecific rabbit antihuman lysozyme serum and reference standard were obtained from Behring Institute, West Germany.


  Observations Top


Lysozyme was found in all the tear samples in measurable quantity. The tear lysozyme levels in the different stages of trachoma and in the healthy subjects are shown in [Table - 1].

Before attempting a comparison between the healthy subjects and the trachoma patients, it is essential to ensure that the trachoma patients, suffering from different stages of the disease, are not a heterogenous group. For this it is useful to compare the lysozyme level among patients at different stages of trachoma. For this purpose an analysis of variance was carried out and the results are given in [Table - 2].

It is clear that the patients in various stages of trachoma do not differ significantly from each other in so far as the lysozyme level is concerned (P>0.05) although on a cursory inspection there appears to be a suggestion that the tear lysozyme level progressively de­creases. It is therefore in order to combine them for a comparison with the healthy group of persons. When the mean lysozyme level among trachoma patients (0.99 mg/ml) is com­pared with that (1.41 mg/ml) among the normal persons the difference was found to be statisti­cally significant (P>0.001).


  Discussion Top


At present the most commonly employed method for the estimation of lysozyme is the lysoplate method introduced by Bonavida and Sapse[7]. However, Johansson and Malmquist[8] observed that the bacteriolytic lysozyme deter­mination is not a specific enzyme assay and is probably influenced to some extent by factors other than the lysozyme activity. The immu­noassay of lysozyme employed by us is less sensitive to disturbances and thus is expected to provide more accurate information about the true lysozyme level in biological fluids. The mean level of lysozyme in healthy subjects by the immunoassay method was 1.41 mg/ml, which is lower than the level (27 mg/ml) reported by Bonavida and Sapse[7] in normal human tears. This supports the contention of Johansson and Malmquist[8] that the bacteriolytic lysozyme level determination is not a specific enzyme assay.

In this study we found lysozyme in tears in all stages of trachoma although its level was significantly lower than that in healthy sub­jects. However, there was no significant diffe­rence in tear lysozyme level between the diffe­rent stages of trachoma.

It is not clear whether the low level of lyso­zyme in tears in subjects suffering from trachoma was inherent, making them prone to infection by the trachoma agents or was the result of trachoma infection that caused structural changes in the lacrimal gland and tubules and interfered with the local production of the enzyme. However, it is interesting to note that even in the earlier stages of the disease the lysozyme level was significantly low.


  Summary Top


Tear lysozyme levels have been measured in 75 healthy subjects and in 73 patients with different stages of trachoma by employing a single radical immunodiffusion technique. The lysozyme was found in all the tear samples in measurable quantity. In healthy subjects, the mean tear lysozyme level was 1.41 mg/ml. In trachoma patients, the mean tear lysozyme level was 0.99 mg/ml, which was significantly low as compared to that in healthy subjects, However, there was no significant difference in the lysozyme level between the different stages of trachoma.


  Acknowledgements Top


Mr. G.P. Mathur, statistician, New Delhi Tuberculosis Centre, New Delhi, has done the statistical analysis of the data.

 
  References Top

1.
Sen, D.K. and Sarin, G.S., 1980, Amer. J Ophthalmol. 90:715.  Back to cited text no. 1
    
2.
Mayer, K., 1948, (Ed.) Sorsby, A. Modern Trends in Ophthalmology. London, Butterworth, Vol. 2, p. 71.  Back to cited text no. 2
    
3.
Minton, L.R., 1965, Amer. J. Ophthalmol. 60 532.  Back to cited text no. 3
    
4.
MacCallan, A.F., 1913, Trachoma and its com plications in Egypt, p. 5 London, Cambridge Univer­sity Press.  Back to cited text no. 4
    
5.
World Health Organization, 1962, Expert Com­mittee on Trachoma Third Report. W.H.O. Tech. Report No. 234, p.9.  Back to cited text no. 5
    
6.
Sen, D.K., Sarin, G.S., Mani, K. and Saha, K., 1976, Brit. J. Ophthalmol. 60 : 302.  Back to cited text no. 6
    
7.
Bonavida, B. and Sapse, A.T., 1968, Amer J. Ophthalmol. 66 :70.  Back to cited text no. 7
    
8.
Johansson, B.G, and Malmquist, J., 1971, Scand J, Clin. & Lab. Invest. 27 : 255.  Back to cited text no. 8
    



 
 
    Tables

  [Table - 1], [Table - 2]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Materials and me...
Observations
Discussion
Summary
Acknowledgements
References
Article Tables

 Article Access Statistics
    Viewed1611    
    Printed47    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal